The recent sale from a key insider at the current share pric...
The recent sale from a key insider at the current share price of US$14.12 raises concerns, despite insiders holding sizable shares in the company. This trend combined with limited recent insider buying causes a cautious outlook towards the company's stock.
Avadel Pharmaceuticals Independent Director Mark McCamish Sells 53% Of Holding
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment